National Taiwan University Hospital
Taipei, 100, Taiwan
NCT Number: NCT01388803
A retrospective study to demonstrate the optimal depth of right side bronchial blocker for complete right lung separation. Data were collected from all patients who completed right side VATS with right side BB from Jan 2010 through Nov 2010.
Looking for future studies?
Notify Me18 year–77 year
All sexes
Observational
Taipei, 100, Taiwan
After general anesthesia, an 8.0 mm internal-diameter single-lumen endotracheal tube was inserted orally. An independent Coopdech bronchial blocker, which has a formed-curvature near the catheter tip, was directly inserted through the single-lumen endotracheal tube into right main bronchus. Chest inspection, auscultation, fiberoptic bronchoscopy confirmation, if necessary, by visualizing the blocker cuff located at right main bronchus just below the carina was performed firstly. After placing patients in left decubitus position, the position of BB was reconfirmed by auscultation firstly; then complete collapse of the right upper lobe was adjust, if necessary and reconfirmed on the video of thoracoscopy by both surgeon and anesthesiologists. The depth of BB and the need of fiberoptic bronchoscope were recorded. All the patients were extubated in operation room after completion of operation with optimal analgesia. Data collected included; age, sex, body height and weight and the depth of right-sided BB from incisor was then recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Taiwan University Hospital
Other
Right Side Bronchial Blocker in Video-assisted Thoracoscopic Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03645915
Disease, Lung Diseases
Amiens, France
View Trial DetailsNCT05555342
Lung Diseases, Lung Neoplasms
Orange, California, United States
View Trial DetailsNCT04974632
Lung Diseases, Lung Neoplasms
Taoyuan, Taiwan
View Trial DetailsNCT03881410
Lung Diseases, Lung Neoplasms
Taipei, Taiwan
View Trial Details